Business

CeraTattva Innotech Secures Rs 1.31 Crores in Funding Led by Campus Angels Network and Forge Innovation & Ventures

Jul 12, 2024

VMPL
Chennai (Tamil Nadu) [India], July 12: CeraTattva InnoTech Private Limited, an innovator in pre-ceramic precursors/polymers and ceramic products, incubated at IIT Madras Incubation Cell and accelerated by Forge Innovation & Ventures, delivers advanced high temperature material solutions for space, defense, energy and automotive sectors, proudly announces the successful closing of a funding round totaling Rs1.31 Crores.
The funding round was co-led by Campus Angels Network, an angel network dedicated to supporting deep tech startups incubated at university campuses across India, and Forge Innovation & Ventures - leading vertically integrated enterprise driving national scale Industrial transformation through open innovation, startup accelerator, and tech ventures programs for government and corporate sectors focused on seeding, accelerating, and scaling hardware tech innovations and startups.
Leadership Insights
Dr. Ganesh Babu, Founder & CEO, CeraTattva: "This funding will significantly enhance our production capabilities for scaling up and deploying our groundbreaking material solutions across key industries, steering us towards a future driven by innovation and advanced technologies.
Chandran Krishnan, Managing Director & CEO, Campus Angels Network: "CeraTattva's dedication to material science advancements aligns seamlessly with our investment philosophy of supporting deep tech companies with high market potential. We are excited to back their vision and believe their innovative polymer-to-ceramic technology will set new standards in aerospace and defense, driving significant industrial transformation."
Vish Sahasranamam, Co-Founder & CEO, Forge Innovation & Ventures: "CeraTattva's transformation of polymers into ceramics represents a breakthrough in materials science, especially for high-temperature applications in aerospace and defense. Their advanced ceramic products offer superior thermal stability, creep resistance, and oxidation resistance, resulting in lower processing temperatures and cost savings. This investment aligns with our mission to seed, accelerate and scale hardware technologies & innovations to drive national scale industrial transformation.
Strategic Investment
The funds will support the establishment of a pilot production facility, product upgrades, market expansion and building a robust team to accelerate CeraTattva's vision to become the new-age materials tech startup and manufacturer.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025